{"id":"adult-bone-marrow-stem-cells","safety":{"commonSideEffects":[{"rate":"null","effect":"Graft-versus-host disease"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is done by introducing healthy stem cells into the body, which can then differentiate into various cell types to replace damaged or diseased cells. The exact mechanism of action is complex and not fully understood, but it is thought to involve the differentiation of stem cells into various cell types, including immune cells, blood cells, and other cell types.","oneSentence":"Adult Bone Marrow Stem Cells are used to repair or replace damaged or diseased cells in the body.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:18:39.589Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of various conditions, including autoimmune diseases, blood disorders, and certain types of cancer"}]},"trialDetails":[{"nctId":"NCT06954987","phase":"PHASE2","title":"Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-07-17","conditions":"Acute Myeloid Leukemia","enrollment":244},{"nctId":"NCT00576979","phase":"PHASE1, PHASE2","title":"Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2008-03-04","conditions":"Leukemia","enrollment":51},{"nctId":"NCT05796570","phase":"PHASE2","title":"A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies","status":"RECRUITING","sponsor":"Franziska Wachter","startDate":"2023-04-19","conditions":"Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloid Malignancies","enrollment":37},{"nctId":"NCT06752694","phase":"PHASE2","title":"Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-09-25","conditions":"Aplastic Anemia","enrollment":20},{"nctId":"NCT05350748","phase":"","title":"Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-08-18","conditions":"Myelodysplastic Syndromes","enrollment":1100},{"nctId":"NCT07225985","phase":"PHASE1, PHASE2","title":"Pralatrexate With Bendamustine and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2026-05-01","conditions":"Recurrent T-Cell Non-Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma","enrollment":50},{"nctId":"NCT06915233","phase":"PHASE3","title":"A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle","status":"RECRUITING","sponsor":"Vericel Corporation","startDate":"2026-03","conditions":"Chondral Defect, Articular Cartilage Defect","enrollment":309},{"nctId":"NCT04375631","phase":"PHASE1","title":"CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2020-12-03","conditions":"Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome","enrollment":120},{"nctId":"NCT05600426","phase":"PHASE3","title":"A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2023-01-25","conditions":"Severe Aplastic Anemia","enrollment":53},{"nctId":"NCT01652209","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.","status":"COMPLETED","sponsor":"Pharmicell Co., Ltd.","startDate":"2013-09-01","conditions":"Acute Myocardial Infarction","enrollment":90},{"nctId":"NCT05456191","phase":"PHASE3","title":"A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-11-21","conditions":"Philadelphia Chromosome-Positive Chronic Myeloid Leukemia","enrollment":568},{"nctId":"NCT06001385","phase":"PHASE2","title":"HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2023-12-08","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia","enrollment":313},{"nctId":"NCT07386548","phase":"NA","title":"Biologic Injection For Adults With Lumbar Disc Herniation","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-01","conditions":"Degenerative Disc Disease, DDD, Degenerative Disc Disease Lumbar","enrollment":90},{"nctId":"NCT07046078","phase":"PHASE2","title":"Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-09-26","conditions":"Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia","enrollment":20},{"nctId":"NCT01736059","phase":"PHASE1","title":"Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Davis","startDate":"2012-07","conditions":"Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion","enrollment":15},{"nctId":"NCT07362225","phase":"","title":"MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)","status":"RECRUITING","sponsor":"MPN Research Foundation","startDate":"2025-09-26","conditions":"Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV)","enrollment":5000},{"nctId":"NCT06013423","phase":"PHASE2","title":"Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2024-07-23","conditions":"Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":54},{"nctId":"NCT04528355","phase":"","title":"Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2020-08-20","conditions":"Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)","enrollment":50},{"nctId":"NCT05457556","phase":"PHASE3","title":"Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2023-03-15","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia","enrollment":435},{"nctId":"NCT03013998","phase":"PHASE1, PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":"Previously Untreated Relapsed Refractory Acute Myeloid Leukemia","enrollment":3000},{"nctId":"NCT06447987","phase":"PHASE1","title":"Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-11-06","conditions":"Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia","enrollment":24},{"nctId":"NCT01962415","phase":"PHASE2","title":"Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2014-02-04","conditions":"Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)","enrollment":100},{"nctId":"NCT00534469","phase":"PHASE2","title":"Auto BMT for Non-M3 AML in 1st Remission in Pts </=60y of Age Using Busulfan/FTBI & VP16 as a Prep R","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2000-02-08","conditions":"Leukemia","enrollment":60},{"nctId":"NCT02003222","phase":"PHASE3","title":"Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-05-19","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative","enrollment":488},{"nctId":"NCT02194868","phase":"","title":"Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem Cell Transplantation (HSCT)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-02-02","conditions":"Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies","enrollment":57},{"nctId":"NCT03326921","phase":"PHASE1","title":"HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2018-02-23","conditions":"Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia","enrollment":24},{"nctId":"NCT06928662","phase":"PHASE1, PHASE2","title":"Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-09-23","conditions":"Acute Myeloid Leukemia, Acute Undifferentiated Leukemia, Mixed Phenotype Acute Leukemia","enrollment":36},{"nctId":"NCT05236764","phase":"NA","title":"Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2023-12-06","conditions":"Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes","enrollment":3},{"nctId":"NCT03779854","phase":"PHASE2","title":"Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2019-08-29","conditions":"Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage","enrollment":68},{"nctId":"NCT05854615","phase":"PHASE4","title":"Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease","status":"RECRUITING","sponsor":"Cell Biopeutics Resources Sdn Bhd","startDate":"2024-01-01","conditions":"Critical Limb Ischemia, Buerger's Disease","enrollment":3},{"nctId":"NCT01966367","phase":"PHASE1, PHASE2","title":"CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diane George","startDate":"2013-03","conditions":"Bone Marrow Failure Syndrome, Severe Aplastic Anemia, Severe Congenital Neutropenia","enrollment":37},{"nctId":"NCT03653338","phase":"PHASE1, PHASE2","title":"T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2018-08-02","conditions":"Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia","enrollment":5},{"nctId":"NCT02924571","phase":"NA","title":"BMAC & Allograft vs BMP-2","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2018-07-24","conditions":"Spinal Fusion","enrollment":59},{"nctId":"NCT06412497","phase":"PHASE2","title":"MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-06-05","conditions":"Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia","enrollment":60},{"nctId":"NCT00534430","phase":"PHASE2","title":"Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2000-02-29","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":30},{"nctId":"NCT05124288","phase":"","title":"Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic Pathways","status":"RECRUITING","sponsor":"Ciceri Fabio","startDate":"2022-07-18","conditions":"Acute Myeloid Leukemia, in Relapse","enrollment":500},{"nctId":"NCT01497184","phase":"PHASE1","title":"Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-12","conditions":"Leukemia, Lymphoma","enrollment":95},{"nctId":"NCT04747912","phase":"PHASE2","title":"Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-03-02","conditions":"Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, ph+ Acute Lymphoblastic Leukemia","enrollment":25},{"nctId":"NCT05507099","phase":"PHASE2","title":"Stem Cell Study in Osteoarthritis of the Knee and Hip Joints","status":"RECRUITING","sponsor":"Grigory Karmy","startDate":"2022-08-23","conditions":"Osteoarthritis","enrollment":400},{"nctId":"NCT06361329","phase":"PHASE3","title":"Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2024-04-03","conditions":"ETP-ALL","enrollment":81},{"nctId":"NCT05836883","phase":"PHASE1, PHASE2","title":"Study of ExoFlo for the Treatment of Perianal Fistulas","status":"TERMINATED","sponsor":"Direct Biologics, LLC","startDate":"2023-08-28","conditions":"Perianal Fistula, Crohn's Disease","enrollment":5},{"nctId":"NCT05130983","phase":"PHASE1","title":"Study of ExoFlo for the Treatment of Medically Refractory Crohn's Disease","status":"TERMINATED","sponsor":"Direct Biologics, LLC","startDate":"2023-01-23","conditions":"Crohn Disease, Inflammatory Bowel Diseases","enrollment":3},{"nctId":"NCT05176366","phase":"PHASE1","title":"Study of ExoFlo for the Treatment of Medically Refractory Ulcerative Colitis","status":"TERMINATED","sponsor":"Direct Biologics, LLC","startDate":"2022-12-19","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":4},{"nctId":"NCT06200441","phase":"","title":"Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease","status":"WITHDRAWN","sponsor":"Ugur Arzu Kulu","startDate":"2023-11-15","conditions":"Acute Myeloid Leukemia, Adult, Graft Versus Host Disease, Endothelial Dysfunction","enrollment":""},{"nctId":"NCT05086939","phase":"PHASE3","title":"Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León","startDate":"2021-05-26","conditions":"Knee Osteoarthritis","enrollment":124},{"nctId":"NCT05177731","phase":"PHASE3","title":"Venetoclax + Decitabine vs. \"7+3\" Induction Chemotherapy in Young AML","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chen Suning","startDate":"2022-03-01","conditions":"AML, Adult, Chemotherapy Effect","enrollment":188},{"nctId":"NCT04397796","phase":"PHASE1","title":"Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation","status":"TERMINATED","sponsor":"ImmunityBio, Inc.","startDate":"2020-08-03","conditions":"COVID","enrollment":4},{"nctId":"NCT02297256","phase":"NA","title":"Prospective Study of Thoracolumbar Spinal Fusion Graft","status":"ACTIVE_NOT_RECRUITING","sponsor":"NYU Langone Health","startDate":"2012-08","conditions":"Lumbar Degenerative Disc Disease","enrollment":17},{"nctId":"NCT02061800","phase":"PHASE1, PHASE2","title":"CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Diane George","startDate":"2013-06-03","conditions":"Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS)","enrollment":14},{"nctId":"NCT03821610","phase":"PHASE2","title":"A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Birmingham","startDate":"2018-11-22","conditions":"Acute Lymphoblastic Leukemia","enrollment":242},{"nctId":"NCT03356821","phase":"PHASE1, PHASE2","title":"Perinatal Arterial Stroke Treated With Stromal Cells Intranasally","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2020-02-11","conditions":"Perinatal Arterial Ischemic Stroke, Neonatal Stroke","enrollment":10},{"nctId":"NCT02525432","phase":"PHASE2","title":"Autologous Stem Cell Study for Adult TBI (Phase 2b)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2016-11-21","conditions":"Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury)","enrollment":37},{"nctId":"NCT05179057","phase":"PHASE3","title":"Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation","status":"TERMINATED","sponsor":"AlloVir","startDate":"2022-04-26","conditions":"Adenovirus Infection","enrollment":57},{"nctId":"NCT03724136","phase":"NA","title":"Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study","status":"ENROLLING_BY_INVITATION","sponsor":"MD Stem Cells","startDate":"2018-10-24","conditions":"Alzheimer Disease, Alzheimer Dementia, Vascular Dementia","enrollment":100},{"nctId":"NCT00630565","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2006-07-26","conditions":"Leukemia","enrollment":12},{"nctId":"NCT03807804","phase":"PHASE2","title":"Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Healios K.K.","startDate":"2019-01-01","conditions":"Respiratory Distress Syndrome, Adult","enrollment":35},{"nctId":"NCT04478474","phase":"","title":"Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients","status":"COMPLETED","sponsor":"New York Medical College","startDate":"2020-09-15","conditions":"Cytomegalovirus Infections","enrollment":100},{"nctId":"NCT00611351","phase":"PHASE2","title":"Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2005-06-07","conditions":"Graft Versus Host Disease, Leukemia, Lymphoma","enrollment":5},{"nctId":"NCT00080886","phase":"PHASE2","title":"Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2002-05-08","conditions":"Lymphoma","enrollment":68},{"nctId":"NCT00574496","phase":"PHASE2","title":"Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2007-11-13","conditions":"Lymphoma","enrollment":25},{"nctId":"NCT00898456","phase":"","title":"Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2006-10","conditions":"Leukemia","enrollment":600},{"nctId":"NCT03886909","phase":"NA","title":"Impact of Prehabilitation in Oncology Via Exercise- Bone Marrow Transplant","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2019-06-28","conditions":"Hematopoietic Stem Cell Transplant, Hematologic Diseases, Physical Activity","enrollment":84},{"nctId":"NCT00057954","phase":"PHASE2","title":"Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma","status":"TERMINATED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2005-11-09","conditions":"Lymphoma","enrollment":6},{"nctId":"NCT00002514","phase":"PHASE3","title":"Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"1993-05-07","conditions":"Leukemia","enrollment":1929},{"nctId":"NCT00641030","phase":"PHASE1","title":"Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2007-07","conditions":"Leukemia, Myelodysplastic Syndromes","enrollment":20},{"nctId":"NCT05392894","phase":"PHASE3","title":"RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease","status":"RECRUITING","sponsor":"King's College Hospital NHS Trust","startDate":"2023-02-23","conditions":"Sickle Cell Disease","enrollment":120},{"nctId":"NCT02866721","phase":"PHASE1","title":"Safety and Tolerability Study of Allogeneic Mesenchymal Stem Cell Infusion in Adults With Cystic Fibrosis","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2016-08","conditions":"Cystic Fibrosis","enrollment":14},{"nctId":"NCT00423514","phase":"PHASE1, PHASE2","title":"Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-11-20","conditions":"Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes","enrollment":38},{"nctId":"NCT03564470","phase":"PHASE2, PHASE3","title":"Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2016-02-14","conditions":"Leukemia, Leukemia, Acute, Leukemia, Lymphoblastic","enrollment":120},{"nctId":"NCT04548583","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis","status":"UNKNOWN","sponsor":"The Cleveland Clinic","startDate":"2020-11-04","conditions":"Crohn Colitis","enrollment":24},{"nctId":"NCT04791878","phase":"PHASE1","title":"Study of Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease","status":"UNKNOWN","sponsor":"Amy Lightner","startDate":"2021-04-01","conditions":"Perianal Fistula Due to Crohn's Disease (Disorder)","enrollment":10},{"nctId":"NCT04543994","phase":"PHASE1, PHASE2","title":"Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)","status":"UNKNOWN","sponsor":"The Cleveland Clinic","startDate":"2020-11-10","conditions":"Ulcerative Colitis","enrollment":24},{"nctId":"NCT04519697","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease","status":"UNKNOWN","sponsor":"Amy Lightner","startDate":"2020-10-28","conditions":"Rectovaginal Fistula, Crohn Disease, Crohn Disease of Vulva","enrollment":40},{"nctId":"NCT04519671","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease","status":"UNKNOWN","sponsor":"Amy Lightner","startDate":"2020-11-19","conditions":"Perianal Crohn Disease, Perianal Fistula, Crohn Disease","enrollment":40},{"nctId":"NCT00136903","phase":"PHASE2","title":"Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)","status":"COMPLETED","sponsor":"Mesoblast, Inc.","startDate":"2005-04-27","conditions":"Graft Vs Host Disease","enrollment":32},{"nctId":"NCT01531348","phase":"PHASE1","title":"Intravitreal Injection of MSCs in Retinitis Pigmentosa","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2012-04","conditions":"Retinitis Pigmentosa","enrollment":14},{"nctId":"NCT01020539","phase":"PHASE1","title":"Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia","status":"COMPLETED","sponsor":"Columbia University","startDate":"2002-09-11","conditions":"Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia","enrollment":18},{"nctId":"NCT04246840","phase":"","title":"Study Through Imaging of Visceral Lymphoid Organs in Patients With SCID Who Have Recieved Bone Marrow Allograft","status":"COMPLETED","sponsor":"Association Pour l'Aide a la Recherche en Immunologie Pediatrique","startDate":"2020-01-13","conditions":"Severe Combined Immunodeficiency","enrollment":18},{"nctId":"NCT00562978","phase":"PHASE1, PHASE2","title":"Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an AHSCT in Non-Hodgkin's Lymphoma Patients","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2000-05-16","conditions":"Lymphoma","enrollment":54},{"nctId":"NCT01468064","phase":"PHASE1, PHASE2","title":"Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke","status":"COMPLETED","sponsor":"Southern Medical University, China","startDate":"2011-11","conditions":"Stroke, Infarction, Middle Cerebral Artery","enrollment":20},{"nctId":"NCT04007081","phase":"NA","title":"Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2019-10-18","conditions":"Xerostomia, Head and Neck Cancer","enrollment":12},{"nctId":"NCT00606723","phase":"PHASE3","title":"Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML","status":"COMPLETED","sponsor":"Hannover Medical School","startDate":"2010-04","conditions":"Acute Myeloid Leukemia (AML)","enrollment":154},{"nctId":"NCT01338987","phase":"PHASE2","title":"Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2011-04-19","conditions":"Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia","enrollment":76},{"nctId":"NCT02194439","phase":"","title":"Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease","status":"COMPLETED","sponsor":"Indiana University","startDate":"2014-01","conditions":"Graft-Versus-Host Disease","enrollment":415},{"nctId":"NCT00004031","phase":"PHASE3","title":"SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"SWOG Cancer Research Network","startDate":"1997-07","conditions":"Lymphoma","enrollment":397},{"nctId":"NCT02282514","phase":"PHASE1, PHASE2","title":"Stem Cell Transplantation for Stiff Person Syndrome (SPS)","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2014-10","conditions":"Stiff-Person Syndrome","enrollment":23},{"nctId":"NCT01242774","phase":"PHASE1","title":"Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-10","conditions":"Acute Myeloid Leukemia (AML)","enrollment":46},{"nctId":"NCT00612716","phase":"PHASE2","title":"Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"1999-10-06","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":6},{"nctId":"NCT02033278","phase":"PHASE2","title":"Infusion Intracoronary of Mononuclear Autologous Adult no Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients With Idiopathic Dilated Cardiomyopathy and Heart Failure.","status":"TERMINATED","sponsor":"Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud","startDate":"2014-01-06","conditions":"Idiopathic Dilated Cardiomyopathy","enrollment":27},{"nctId":"NCT04492501","phase":"NA","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"Covid19, Cytokine Release Syndrome, Critical Illness","enrollment":600},{"nctId":"NCT00068523","phase":"NA","title":"Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2003-06","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":10},{"nctId":"NCT01106417","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion","status":"COMPLETED","sponsor":"Mesoblast, Ltd.","startDate":"2010-06","conditions":"Cervical Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis","enrollment":12},{"nctId":"NCT00303719","phase":"PHASE2","title":"Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-03-26","conditions":"Kidney Cancer, Leukemia, Lymphoma","enrollment":342},{"nctId":"NCT00566696","phase":"PHASE2","title":"Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-12-14","conditions":"Leukemia, Acute Lymphocytic (ALL), Leukemia, Myeloid, Acute(AML), Leukemia, Myeloid, Chronic(CML)","enrollment":73},{"nctId":"NCT00765453","phase":"NA","title":"Bone Marrow Derived Adult Stem Cells for Acute Anterior Myocardial Infarction","status":"COMPLETED","sponsor":"Barts & The London NHS Trust","startDate":"2008-03","conditions":"Acute Myocardial Infarction","enrollment":100},{"nctId":"NCT00007813","phase":"PHASE1","title":"Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"1997-05-31","conditions":"Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor","enrollment":21},{"nctId":"NCT00053989","phase":"PHASE2","title":"NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2002-01-29","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":41},{"nctId":"NCT02495766","phase":"PHASE1, PHASE2","title":"Autologous Mesenchymal Stromal Cells for Multiple Sclerosis","status":"COMPLETED","sponsor":"Banc de Sang i Teixits","startDate":"2015-05-11","conditions":"Relapsing-Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis","enrollment":8},{"nctId":"NCT00001637","phase":"PHASE2","title":"Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"1997-09-29","conditions":"Chronic Lymphocytic Leukemia, Graft vs Host Disease, Leukemia","enrollment":28},{"nctId":"NCT00003270","phase":"PHASE2","title":"Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"1997-09-04","conditions":"Graft Versus Host Disease, Leukemia, Lymphoma","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":58,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Adult Bone Marrow Stem Cells","genericName":"Adult Bone Marrow Stem Cells","companyName":"Global Cell Med","companyId":"global-cell-med","modality":"Biologic","firstApprovalDate":"","aiSummary":"Adult Bone Marrow Stem Cells are used to repair or replace damaged or diseased cells in the body. Used for Treatment of various conditions, including autoimmune diseases, blood disorders, and certain types of cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}